Toth Financial Advisory’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.82K | Hold |
100
| – | – | ﹤0.01% | 508 |
|
|
2025
Q1 | $7.25K | Sell |
100
-20
| -17% | -$1.45K | ﹤0.01% | 483 |
|
|
2024
Q4 | $8.88K | Sell |
120
-30
| -20% | -$2.22K | ﹤0.01% | 459 |
|
|
2024
Q3 | $9.9K | Sell |
150
-25
| -14% | -$1.65K | ﹤0.01% | 453 |
|
|
2024
Q2 | $16.2K | Hold |
175
| – | – | ﹤0.01% | 417 |
|
|
2024
Q1 | $16.7K | Sell |
175
-120
| -41% | -$11.5K | ﹤0.01% | 399 |
|
|
2023
Q4 | $22.5K | Sell |
295
-65
| -18% | -$4.96K | ﹤0.01% | 373 |
|
|
2023
Q3 | $24.9K | Buy |
360
+61
| +20% | +$4.23K | ﹤0.01% | 343 |
|
|
2023
Q2 | $28.2K | Hold |
299
| – | – | ﹤0.01% | 338 |
|
|
2023
Q1 | $24.7K | Buy |
+299
| New | +$24.7K | ﹤0.01% | 359 |
|
|
2022
Q4 | – | Sell |
-439
| Closed | -$36K | – | 739 |
|
|
2022
Q3 | $36K | Buy |
439
+115
| +35% | +$9.43K | 0.01% | 307 |
|
|
2022
Q2 | $31K | Hold |
324
| – | – | 0.01% | 326 |
|
|
2022
Q1 | $38K | Buy |
+324
| New | +$38K | 0.01% | 313 |
|